Philip Morris International (NYSE:PM) reported first-quarter 2026 financial results that surpassed analyst expectations for profitability, driven by the continued strong performance of its international smoke-free portfolio. While total revenue narrowly missed consensus estimates, robust earnings growth and a reaffirmed full-year outlook appear to have been welcomed by investors, with the stock trading higher in pre-market activity.
Earnings and Revenue Versus Estimates
The tobacco and nicotine giant reported adjusted diluted earnings per share (EPS) of $1.96 for the quarter, a significant 16% increase over the prior year period. This result comfortably exceeded the analyst consensus estimate of $1.89. The company attributed the strong bottom-line growth to pricing power, operating leverage, and an increasing mix of higher-margin smoke-free products.
On the top line, net revenues reached $10.15 billion, marking a 9.1% reported increase. However, this figure came in slightly below the analyst estimate of approximately $10.19 billion. The revenue performance was a tale of two segments:
- International Smoke-Free Business: Delivered outstanding growth, with net revenues surging 24.7% (15.8% organically) to $3.8 billion.
- U.S. Segment: Experienced a significant decline, with net revenues falling 30.8% to $622 million, which the company attributed to inventory normalization in the trade and a tough promotional comparison for its ZYN nicotine pouches.
Market Reaction and Price Action
The market's initial reaction to the mixed report has been positive, focusing on the earnings beat and strategic progress. Following the earnings release, PMI's stock was up approximately 3.1% in pre-market trading. This positive movement suggests investors are emphasizing the company's ability to grow profits ahead of expectations and are likely encouraged by the sustained momentum in its core smoke-free transformation outside the United States.
Recent stock performance had been under pressure, with shares down over 6% in the past month, potentially reflecting broader market concerns or sector headwinds. The post-earnings bounce indicates the results may have alleviated some of those near-term concerns.
Key Highlights from the Quarter
The first-quarter report underscored the accelerating strategic shift at PMI. The smoke-free business now accounts for 43% of total net revenues, up 1.3 percentage points from a year ago.
- IQOS Leads the Charge: The heated tobacco unit system remains the primary growth engine. IQOS shipment volume grew 11.3%, and the brand surpassed Marlboro to become the number one nicotine "brand" in combined cigarette and heated tobacco volume in markets where it is present. PMI holds an estimated 77% volume share of the global heated tobacco category.
- Geographic Strength: Growth was broad-based, with strong performances in Japan, Europe (led by Italy, Greece, and Germany), and key cities outside those regions like Mexico City and Seoul. The launch in Taiwan was highlighted as the most successful major launch to date.
- U.S. Segment Normalization: As anticipated, the U.S. business faced a challenging quarter due to the normalization of trade inventories for ZYN pouches. While shipment volumes declined, the company noted that consumer offtake—a measure of actual consumption—grew by an estimated 10%.
Updated 2026 Full-Year Outlook
Management updated its full-year forecast, specifically for currency impacts, while maintaining the core operational guidance. The company now expects full-year 2026 adjusted diluted EPS in a range of $8.36 to $8.51. This represents projected growth of 10.9% to 12.9% over 2025's adjusted EPS of $7.54.
When excluding an estimated favorable currency impact, the forecast translates to organic growth of 7.5% to 9.5%. This outlook appears generally in line with or slightly above analyst expectations, which had been calling for full-year 2026 sales of approximately $44.93 billion and EPS estimates around $8.71. The company's guidance assumes high-single-digit shipment volume growth for its smoke-free products and net revenue organic growth of 5% to 7%.
For the upcoming second quarter, PMI provided adjusted diluted EPS guidance of $2.02 to $2.07, which brackets the current analyst consensus estimate of $2.04.
For a detailed look at Philip Morris International's historical earnings and future analyst projections, you can review the data here and here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice, financial analysis, or a recommendation to buy, sell, or hold any security. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.